Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00362076 · ClinicalTrials.gov registry record
The Role of Motion in Infants' Ability to Categorize
A clinical trial of Child Development, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- 941
- Enrollment target
- 1
- Study location
NCT00362076: Completed study of Child Development, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
NCT00362076 is a study of Child Development that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 941 participants, below the 1,064-participant average among 32 other Child Development trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00362076, a study of Child Development, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- 941 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is concerned with psychological and physiological development in infants. Specifically, researchers are interested in when and how babies are able to group similar objects, like animals or vehicles, into the same category. This study will investigate whether motion aids in the categorization process and allows for earlier demonstration of this competency. Previous studies have demonstrated that the ability to categorize stationary objects or images of objects, is present by 6 months of age. This study is made up of three experiments to test: 1. The infant's ability to categorize photographic stimuli. 2. The infant's ability to categorize moving stimuli. 3. The infant's ability to transfer knowledge from moving to photographic stimuli. Initially, the abilities of 3- and 6-month-old infants will be compared. It is also possible that 9-month-old infants will be tested. Data will consist of looking at time measures (level of attention to displays) and heart rate. The ability of infants to transfer category knowledge will support the view that motion is a source of information for object categorization.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 941 participants |
| Start Date | 1998-09-03 |
| Est. Completion | 2012-04-19 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
What the finished NCT00362076 record still lists
NCT00362076 is an observational study that tracks outcomes without assigning an intervention. The registered 941 participants enrollment target is mid-sized for trials with a published cap, below the 1,064-participant average among 32 other Child Development trials with a reported enrollment target (12% lower).
The record links to 1 condition, with Child Development appearing as the primary indexed condition, and to 0 interventions.
NCT00362076 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00362076 about?
NCT00362076 is a clinical study titled "The Role of Motion in Infants' Ability to Categorize". This study is concerned with psychological and physiological development in infants. Specifically, researchers are interested in when and how babies are able to group similar objects, like animals or vehicles, into the same category. This study will investigate whether motion aids in the categorizat...
What is the current status of trial NCT00362076?
This trial is currently completed. The enrollment target is 941 participants. The study started on 1998-09-03. Estimated completion is 2012-04-19.
What conditions does trial NCT00362076 study?
This clinical trial studies the following conditions: Child Development.
Who is sponsoring clinical trial NCT00362076?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00362076 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Child Development
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00362076's enrollment target sits among peer trials
941 6th of 32 higher than 27 of 32 other Child Development trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Child Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants
RECRUITING · NA
-
Interventions in Mathematics and Cognitive Skills
RECRUITING · NA
-
In Vitro Fertilization (IVF) and Prenatal Effects Independent of Genetics
RECRUITING
-
PRT for Adolescents With High Functioning Autism
RECRUITING · NA
-
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
RECRUITING
-
Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06808334 · 942 participants
CLAiR Pivotal Study
- NCT07190209 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- NCT07190222 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- NCT03075696 · 940 participants · Phase 1
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI